A Miami attorney, who prevailed on behalf of pharmaceutical client GlaxoSmithKline in Massachusetts federal court after years of litigation, is expecting only a short breather.

Hildy Sastre, a partner at Shook, Hardy & Bacon in Miami, argued the winning motion in the multidistrict litigation, or MDLs, involving her client GlaxoSmithKline, whose product, Zofran, allegedly caused birth defects in more than 450 babies whose mothers used the medication during pregnancy.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]